Pembrolizumab-related sclerosing cholangitis manifested by a pruned-tree appearance of the bile ducts

Jpn J Clin Oncol. 2021 Apr 1;51(4):666-667. doi: 10.1093/jjco/hyaa201.

Authors

Masaki Takinami¹, Akira Ono¹, Michihisa Moriguchi^{2

3}, Toshiaki Takahashi¹

Affiliations

¹ Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
² Division of Interventional Radiology, Shizuoka Cancer Center, Shizuoka, Japan.
³ Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

PMID: 33164060
DOI: 10.1093/jjco/hyaa201

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Bile Ducts
Cholangitis, Sclerosing* / diagnostic imaging
Cholangitis, Sclerosing* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab